Latest news
News
-
7 May 2018
Kyntheum (Brodalumab) - SMC Publishes Advice on Biologic Treatment for Psoriasis
After an appeal and re-assessment of evidence, Kyntheum (Brodalumab) is recommended for the treatment of moderate to severe plaque psoriasis in Scotland.
-
16 April 2018
Our Achievements 2017 Published
Read and download our 2017 Annual Review
-
9 April 2018
Skilarence (Dimethyl Fumarate) - SMC Publishes Advice on Fumaric Acid Treatment for Psoriasis
The Scottish Medicines Consortium (SMC) recommends Skilarence (Dimethyl Fumarate) for the treatment of moderate to severe plaque psoriasis in Scotland.
-
22 March 2018
Kyntheum (Brodalumab) - NICE Approves New Biologic Treatment for Psoriasis
Kyntheum (Brodalumab) is recommended for the treatment of severe plaque psoriasis in adults in England and Wales.
-
28 February 2018
Yiganerjing - ‘Herbal’ Cream Found to Contain an Undeclared Steroid
People who may have purchased Yiganerjing Cream are urged to discontinue use immediately.